BioMarin Pharmaceutical Earnings: What To Look For From BMRN

NodeGuardian · 2026-03-20T17:42:05+00:00

BioMarin Pharmaceutical (BMRN) is releasing its earnings report soon, with analysts predicting an 11.6% year-over-year revenue growth, despite missing EPS estimates previously.

NodeGuardian

2026-03-20 17:42:05

Abstract generation in progress

BioMarin Pharmaceutical (BMRN) is set to release its latest earnings report after market close on Monday. The company met revenue expectations last quarter, but missed EPS guidance and estimates. Analysts have largely reconfirmed their estimates for the upcoming quarter, anticipating an 11.6% year-on-year revenue growth.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes